• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺乏充分免疫抑制的多灶性脉络膜炎的疾病进程:一例报告

Course of disease in multifocal choroiditis lacking sufficient immunosuppression: a case report.

作者信息

Schroeder Katharina, Meyer-Ter-Vehn Tobias, Fassnacht-Riederle Heidi, Guthoff Rainer

机构信息

Department of Ophthalmology, University of Duesseldorf, Moorenstr. 5, 40225, Duesseldorf, Germany.

Department of Ophthalmology, University of Wuerzburg, Wuerzburg, Germany.

出版信息

J Med Case Rep. 2016 Oct 24;10(1):298. doi: 10.1186/s13256-016-1069-2.

DOI:10.1186/s13256-016-1069-2
PMID:27776541
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5078967/
Abstract

BACKGROUND

Multifocal choroiditis with panuveitis is a rare disease. The educational merit of this case presentation results from the good documentation and the impressive ocular fundus pictures.

CASE PRESENTATION

We illustrate the 3-year course of disease in a 22-year-old myopic white woman with multifocal choroiditis with panuveitis and secondary choroidal neovascularization. The activity of the disease was evaluated clinically by optical coherence tomography and fluorescein angiography. Choroidal neovascularization was treated by intravitreal bevacizumab (2.5 mg/0.1 ml). Our patient lacked systemic therapy for the first 11 months because of noncompliance.

CONCLUSIONS

The case is remarkable as the delayed onset of peripheral lesions and the additional existence of high myopia made diagnosis difficult. In addition, it demonstrates that full outbreak of disease with multiple central and peripheral fundus lesions and secondary choroidal neovascularization can develop without systemic treatment.

摘要

背景

多灶性脉络膜炎伴全葡萄膜炎是一种罕见疾病。本病例报告的教育价值源于良好的记录以及令人印象深刻的眼底照片。

病例报告

我们阐述了一名22岁近视白人女性患多灶性脉络膜炎伴全葡萄膜炎及继发性脉络膜新生血管形成的3年病程。通过光学相干断层扫描和荧光素血管造影对疾病活动进行临床评估。采用玻璃体内注射贝伐单抗(2.5 mg/0.1 ml)治疗脉络膜新生血管。由于患者不依从,在最初11个月未进行全身治疗。

结论

该病例值得关注,因为周边病变延迟出现以及合并高度近视增加了诊断难度。此外,它表明在未进行全身治疗的情况下,可出现伴有多个中央和周边眼底病变及继发性脉络膜新生血管形成的疾病全面发作。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bae/5078967/654ebc8f430e/13256_2016_1069_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bae/5078967/ccfeabc7b46f/13256_2016_1069_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bae/5078967/654ebc8f430e/13256_2016_1069_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bae/5078967/ccfeabc7b46f/13256_2016_1069_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bae/5078967/654ebc8f430e/13256_2016_1069_Fig2_HTML.jpg

相似文献

1
Course of disease in multifocal choroiditis lacking sufficient immunosuppression: a case report.缺乏充分免疫抑制的多灶性脉络膜炎的疾病进程:一例报告
J Med Case Rep. 2016 Oct 24;10(1):298. doi: 10.1186/s13256-016-1069-2.
2
Three-year visual and anatomic results of administrating intravitreal bevacizumab in inflammatory ocular neovascularization.眼内注射bevacizumab 治疗炎症性眼新生血管的 3 年视力和解剖学结果。
Can J Ophthalmol. 2012 Jun;47(3):269-74. doi: 10.1016/j.jcjo.2012.03.042.
3
Intravitreal ranibizumab in choroidal neovascularisation due to multifocal choroiditis and panuveitis syndrome.玻璃体内注射雷珠单抗治疗多灶性脉络膜炎和全葡萄膜炎综合征所致脉络膜新生血管
BMJ Case Rep. 2013 Jul 17;2013:bcr2013009572. doi: 10.1136/bcr-2013-009572.
4
Intravitreal bevacizumab for juxtafoveal choroidal neovascularization secondary to multifocal choroiditis.玻璃体内注射贝伐单抗治疗多灶性脉络膜炎继发的近黄斑中心凹脉络膜新生血管。
Retina. 2013 May;33(5):953-6. doi: 10.1097/IAE.0b013e318275397c.
5
Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization.玻璃体内雷珠单抗治疗炎症性脉络膜新生血管。
Retina. 2011 May;31(5):871-9. doi: 10.1097/IAE.0b013e3182003ca8.
6
Sequential Optical Coherence Tomographic Angiography for Diagnosis and Treatment of Choroidal Neovascularization in Multifocal Choroiditis.用于多灶性脉络膜炎中脉络膜新生血管诊断和治疗的序列光学相干断层扫描血管造影术
JAMA Ophthalmol. 2015 Sep;133(9):1087-90. doi: 10.1001/jamaophthalmol.2015.1946.
7
Choroidal neovascularisation on optical coherence tomography angiography in punctate inner choroidopathy and multifocal choroiditis.点状内层脉络膜病变和多灶性脉络膜炎患者光学相干断层扫描血管造影中的脉络膜新生血管形成
Br J Ophthalmol. 2017 May;101(5):616-622. doi: 10.1136/bjophthalmol-2016-308806. Epub 2016 Aug 18.
8
Bevacizumab vs photodynamic therapy for choroidal neovascularization in multifocal choroiditis.贝伐单抗与光动力疗法治疗多灶性脉络膜炎性脉络膜新生血管的比较
Arch Ophthalmol. 2010 Sep;128(9):1100-3. doi: 10.1001/archophthalmol.2010.205.
9
Long-Term Outcome of Punctate Inner Choroidopathy or Multifocal Choroiditis with Active Choroidal Neovascularization Managed with Intravitreal Bevacizumab.特发性点状内层脉络膜病变或多灶性脉络膜炎伴脉络膜新生血管活性病变经玻璃体腔内注射贝伐单抗治疗的长期疗效。
Ocul Immunol Inflamm. 2020;28(1):33-38. doi: 10.1080/09273948.2019.1588335. Epub 2019 Apr 17.
10
Optical Coherence Tomography Angiography for Detecting Choroidal Neovascularization Secondary to Punctate Inner Choroidopathy.光学相干断层扫描血管造影术用于检测点状内层脉络膜病变继发的脉络膜新生血管形成。
Ophthalmic Surg Lasers Imaging Retina. 2016 Dec 1;47(12):1157-1161. doi: 10.3928/23258160-20161130-13.

引用本文的文献

1
Presence of Choroidal Caverns in Patients with Posterior and Panuveitis.后部和全葡萄膜炎患者脉络膜腔隙的存在情况。
Biomedicines. 2023 Apr 25;11(5):1268. doi: 10.3390/biomedicines11051268.
2
Imageology features of different types of multifocal choroiditis.不同类型多灶性脉络膜炎的影像学特征
BMC Ophthalmol. 2019 Feb 1;19(1):39. doi: 10.1186/s12886-019-1045-x.

本文引用的文献

1
Risk of choroidal neovascularization among the uveitides.葡萄膜炎相关脉络膜新生血管的风险。
Am J Ophthalmol. 2013 Sep;156(3):468-477.e2. doi: 10.1016/j.ajo.2013.04.040. Epub 2013 Jun 21.
2
Multifocal choroiditis without panuveitis: clinical characteristics and progression.多灶性脉络膜炎而无全葡萄膜炎:临床特征和进展。
Retina. 2014 Jan;34(1):98-107. doi: 10.1097/IAE.0b013e31829234cb.
3
Redefining multifocal choroiditis and panuveitis and punctate inner choroidopathy through multimodal imaging.通过多模态成像重新定义多灶性脉络膜炎和全葡萄膜炎及点状内层脉络膜病变。
Retina. 2013 Jul-Aug;33(7):1315-24. doi: 10.1097/IAE.0b013e318286cc77.
4
Intravitreal bevacizumab for juxtafoveal choroidal neovascularization secondary to multifocal choroiditis.玻璃体内注射贝伐单抗治疗多灶性脉络膜炎继发的近黄斑中心凹脉络膜新生血管。
Retina. 2013 May;33(5):953-6. doi: 10.1097/IAE.0b013e318275397c.
5
[Inflammatory choroidal neovascularisations].[炎症性脉络膜新生血管]
Klin Monbl Augenheilkd. 2012 Sep;229(9):897-904. doi: 10.1055/s-0032-1315249. Epub 2012 Sep 12.
6
Three-year visual and anatomic results of administrating intravitreal bevacizumab in inflammatory ocular neovascularization.眼内注射bevacizumab 治疗炎症性眼新生血管的 3 年视力和解剖学结果。
Can J Ophthalmol. 2012 Jun;47(3):269-74. doi: 10.1016/j.jcjo.2012.03.042.
7
Myopia and inflammation.近视与炎症。
J Ophthalmic Vis Res. 2011 Oct;6(4):270-83.
8
Ranibizumab therapy for choroidal neovascularization secondary to non-age-related macular degeneration causes.雷珠单抗治疗非年龄相关性黄斑变性继发脉络膜新生血管
Clin Exp Ophthalmol. 2012 Jan-Feb;40(1):67-72. doi: 10.1111/j.1442-9071.2011.02719.x. Epub 2011 Dec 23.
9
Bevacizumab vs photodynamic therapy for choroidal neovascularization in multifocal choroiditis.贝伐单抗与光动力疗法治疗多灶性脉络膜炎性脉络膜新生血管的比较
Arch Ophthalmol. 2010 Sep;128(9):1100-3. doi: 10.1001/archophthalmol.2010.205.
10
Bevacizumab (avastin) and ranibizumab (lucentis) for choroidal neovascularization in multifocal choroiditis.贝伐单抗(阿瓦斯汀)和雷珠单抗(兰尼单抗)用于多灶性脉络膜炎性脉络膜新生血管形成
Retina. 2009 Jan;29(1):8-12. doi: 10.1097/IAE.0b013e318187aff9.